Generation of Null Mutants to Elucidate the Role of Bacterial Glycosyltransferases in Bacterial Motility

Summary

Here, we describe the construction of null mutants of Aeromonas in specific glycosyltransferases or regions containing glycosyltransferases, the motility assays, and flagella purification performed to establish the involvement and function of their encoded enzymes in the biosynthesis of a glycan, as well as the role of this glycan in bacterial pathogenesis.

Abstract

The study of glycosylation in prokaryotes is a rapidly growing area. Bacteria harbor different glycosylated structures on their surface whose glycans constitute a strain-specific barcode. The associated glycans show higher diversity in sugar composition and structure than those of eukaryotes and are important in bacterial-host recognition processes and interaction with the environment. In pathogenic bacteria, glycoproteins have been involved in different stages of the infectious process, and glycan modifications can interfere with specific functions of glycoproteins. However, despite the advances made in the understanding of glycan composition, structure, and biosynthesis pathways, understanding of the role of glycoproteins in pathogenicity or interaction with the environment remains very limited. Furthermore, in some bacteria, the enzymes required for protein glycosylation are shared with other polysaccharide biosynthetic pathways, such as lipopolysaccharide and capsule biosynthetic pathways. The functional importance of glycosylation has been elucidated in several bacteria through mutation of specific genes thought to be involved in the glycosylation process and the study of its impact on the expression of the target glycoprotein and the modifying glycan. Mesophilic Aeromonas have a single and O-glycosylated polar flagellum. Flagellar glycans show diversity in carbohydrate composition and chain length between Aeromonas strains. However, all strains analyzed to date show a pseudaminic acid derivative as the linking sugar that modifies serine or threonine residues. The pseudaminic acid derivative is required for polar flagella assembly, and its loss has an impact on adhesion, biofilm formation, and colonization. The protocol detailed in this article describes how the construction of null mutants can be used to understand the involvement of genes or genome regions containing putative glycosyltransferases in the biosynthesis of a flagellar glycan. This includes the potential to understand the function of the glycosyltransferases involved and the role of the glycan. This will be achieved by comparing the glycan deficient mutant to the wild-type strain.

Introduction

Protein glycosylation has been described in both Gram-positive and Gram-negative bacteria and consists of the covalent attachment of a glycan to an amino acid side chain^1,2. In prokaryotes, this process usually occurs via two major enzymatic mechanisms: O- and N-glycosylation³. In O-glycosylation, the glycan is attached to the hydroxyl group of a serine (Ser) or threonine (Thr) residue. In N-glycosylation, the glycan is attached to the side chain amide nitrogen of an asparagine (Asn) residue within the tripeptide sequences Asn-X-Ser/Thr, where X could be any amino acid except proline.

Glycans can adopt linear or branched structures and are composed of monosaccharides or polysaccharides covalently linked by glycosidic bonds. In prokaryotes, glycans usually show diversity in sugar composition and structure in comparison to eukaryotic glycans⁴. Furthermore, two different bacterial glycosylation pathways that differ in how the glycan is assembled and transferred to the acceptor protein have been described: sequential and en bloc glycosylation^5,6. For sequential glycosylation, the complex glycan is built up directly on the protein by successive addition of monosaccharides. In en bloc glycosylation, a pre-assembled glycan is transferred to the protein from a lipid-linked oligosaccharide by a specialized oligosaccharyltransferase (OTase). Both pathways have been shown to be involved in N- and O-glycosylation processes⁷.

Protein glycosylation has a role in modulating the physicochemical and biological properties of proteins. The presence of a glycan can influence how the protein interacts with its ligand, which affects the biological activity of the protein, but can also affect protein stability, solubility, susceptibility to proteolysis, immunogenicity, and microbe-host interactions^8,9. However, several glycosylation parameters, such as the number of glycans, glycan composition, position, and attachment mechanism, could also affect protein function and structure.

Glycosyltransferases (GTs) are the key enzymes in the biosynthesis of complex glycans and glycoconjugates. These enzymes catalyze the glycosidic bond formation between a sugar moiety from an activated donor molecule and a specific substrate acceptor. GTs can use both nucleotides and non-nucleotides as donor molecules and target different substrate acceptors, such as proteins, saccharides, nucleic acids, and lipids¹⁰. Therefore, understanding GTs at the molecular level is important to identify their mechanisms of action and specificity, and also enables understanding how sugar composition of glycans that modify relevant molecules are related to pathogenicity. The Carbohydrate Active enzyme database (CAZy)¹¹ classifies GTs according to their sequence homology, which provides a predictive tool since, in most of the GT families, the structural fold and mechanisms of action are invariant. However, four reasons make it difficult to predict substrate specificity of many GTs: 1) no clear sequence motif determining substrate specificity has been determined in prokaryotes¹², 2) many GTs and OTases show substrate promiscuity^13,14, 3) functional GTs are difficult to produce in high yield in recombinant form and 4) the identification of both donor and acceptor substrates is complex. Despite this, recent mutagenesis studies have made it possible to obtain significant advances in the understanding of catalytic mechanisms and subtract binding of GTs.

In bacteria, O-glycosylation seems to be more prevalent than N-glycosylation. The O-glycosylation sites do not show a consensus sequence, and many of the O-glycosylated proteins are secreted or cell-surface proteins, such as flagellins, pili, or autotransporters¹. Flagellin glycosylation shows variability in the number of acceptor sites, glycan composition, and structure. For example, Burkholderia spp flagellins have only one acceptor site, while in Campylobacter jejuni, flagellins have as many as 19 acceptor sites^15,16. Furthermore, for some bacteria, the glycan is a single monosaccharide, while other bacteria possess heterogeneous glycans compromised of different monosaccharides to form oligosaccharides. This heterogenicity occurs even among strains of the same species. Helicobacter flagellins are only modified by pseudaminic acid (PseAc)¹⁷, and Campylobacter flagellins can be modified by PseAc, the acetamidino form of the pseudaminic acid (PseAm) or legionaminic acid (LegAm), and glycans derived from these sugars with acetyl, N-acetylglucosamine, or propionic substitutions^18,19. In Aeromonas, flagellins are modified by glycans whose composition ranges from a single PseAc acid derivative to a heteropolysaccharide²⁰, and the attachment of glycans to the flagellin monomers is always via a PseAc derivative.

In general, glycosylation of flagellins is essential for flagellar filament assembly, motility, virulence, and host specificity. However, while flagellins of C. jejuni¹⁶, H. pylori^17, and Aeromonas sp.²¹ cannot assemble into filament unless the protein monomers are glycosylated, Pseudomonas spp. and Burkholderia spp.¹⁵ do not require glycosylation for flagella assembly. Furthermore, in some C. jejuni strains, changes in sugar composition of the flagella glycan affect bacterial-host interaction and may play a role in evading certain immune responses¹⁶. Autoagglutination is another phenotypic characteristic affected by modifications in the composition of glycans associated with flagellins. A lower autoagglutination leads to a reduction in the ability to form microcolonies and biofilm²². In some bacteria, the ability of flagella to trigger a pro-inflammatory response was linked to flagellin glycosylation. Thus, in P. aeruginosa, glycosylated flagellin induces a higher pro-inflammatory response than unglycosylated²³.

Aeromonas are Gram-negative bacteria ubiquitous in the environment, which allows them to be at the interface of all One Health components²⁴. Mesophilic Aeromonas have a single polar flagellum, which is constitutively produced. More than half of clinical isolates also express lateral flagellin, inducible in high viscosity media or plates. Different studies have related both flagella types with the early stages of bacterial pathogenesis²⁵. While polar flagellins reported to date are O-glycosylated at 5-8 Ser or Thr residues of its central immunogenic domains, lateral flagellins are not O-glycosylated in all the strains. Although polar flagella glycans from different strains show diversity in their carbohydrate composition and chain length²⁰, the linking sugar has been shown to be a pseudaminic acid derivative.

The goal of this manuscript is to describe a method to obtain null mutants in specific GTs or chromosomal regions containing GTs to analyze their involvement in the biosynthesis of relevant polysaccharides and in bacterial pathogenicity, as well as the role of the glycan itself. As an example, we identify and delete a chromosomal region containing GTs of Aeromonas to establish its involvement in polar flagellin glycosylation and analyze the role of the flagellin glycan. We show how to delete a specific GT to establish its function in the biosynthesis of this glycan and the role of modified glycan. Although using Aeromonas as an example, the principle can be used to identify and study flagella glycosylation islands of other Gram-negative bacteria and analyze the function of GTs involved in the biosynthesis of other glycans such as the O-antigen lipopolysaccharide.

Protocol

The schematic representation of the procedure is shown in Figure 1.

1. Bioinformatic identification of flagella glycosylation island (FGIs) in Aeromonas

1. To identify the PseAc biosynthetic clusters in the Aeromonas genomes, use the tblastn tool from the NCBI database²⁶. First, retrieve orthologous proteins to PseC and PseI of A. piscicola AH-3 (identification codes are OCA61126.1 and OCA61113.1) from databases of sequenced Aeromonas strains, and then use the tblastn tool to search their translated nucleotides sequences.
   NOTE: The pse genes flank the Aeromonas FGIs, with pseB and pseC located at one end of the cluster and pseI at the other end. The location of the rest of the pse genes can be different from one FGI group to another.
2. Given that those polar flagellin genes of many strains are adjacent to the FGIs, use the tblastn from the NCBI database to find orthologous proteins to the polar flagellins FlaA and FlaB of A. piscicola AH-3 (identification codes are OCA61104.1 and OCA61105.1) and the genes that encode them.
3. In addition, Aeromonas FGIs involved in the biosynthesis of heteropolysaccharidic glycans (group II)²⁷ contain several genes encoding enzymes involved in the fatty acid synthesis, such as luxC and luxE. Use the tblastn from the NCBI database to find orthologous proteins to LuxC of A. piscicola AH-3 (identification code is OCA61121.1) and the gene that encodes it.

2. Generation of null mutants in flagella glycosylation island genes

NOTE: This method of mutagenesis is based on the allelic exchange of polymerase chain reaction (PCR) in-frame deletion products using the suicide vector pDM4²⁸ (GenBank: KC795686.1). Replication of pDM4 vector is lambda pir dependent, and the complete allelic exchange is coerced by utilizing the sacB gene located on the vector.

1. Construction of PCR in-frame deletion products.
   1. Design two pairs of primers that amplify DNA regions upstream (A and B primers) and downstream (C and D primers) of the selected gene or region to be deleted (Figure 2B).
   2. Ensure that Primers A and D have more than 600 bp upstream from the start and downstream from the stop, respectively, of the gene or genes to be deleted. These two primers need to include at the 5' end a restriction site for an endonuclease that allows cloning in pDM4.
      NOTE: The restriction site included at the 5' end of A and D primers should not be the same as sites within AB or CD amplicons.
   3. Ensure that Primers B and C are within the gene to be deleted or inside the first and last gene, respectively, of the region to be deleted. Ensure that both primers (B and C) are in-frame and located between 5-6 codons inside the gene. Furthermore, ensure that both primers include at the 5' end a 21 bp complementary sequence (Table 1) that allows joining the DNA amplicons AB and CD.
   4. Grow the selected Aeromonas strain in 5 mL of tryptic soy broth (TSB) overnight (O/N) at 30 °C. Use a commercially available kit for genomic DNA purification and follow the manufacturer's instructions (Table of Materials). Quantify 2 µL of the purified DNA using a spectrophotometer.
      NOTE: Use double distilled water as a blank, with the instrument set to record absorbance at 260 nm. Record absorbance with 2 µL of purified DNA 3-5 times and calculate an average absorbance reading. Use the Beer-Lambert law to calculate the DNA concentration, where A = Ɛ.c.l. wherein "A" is absorbance, "Ɛ" is the molar average extinction coefficient for DNA, "c" is DNA concentration, and "l" is the path length (refer to the manufacturer's instruction for the path length of each instrument).
   5. Use 100 ng of purified chromosomal DNA as the template in two sets of asymmetric PCRs with A-B and C-D primers (Table of Materials). Use a 10:1 molar ratio of A:B and D:C primer pairs (Supplementary Material).
      NOTE: Asymmetric PCRs allow the preferential amplification of one strand of the template more than the other.
   6. Analyze the PCR products by electrophoresis in a 1% agarose gel. Use TAE (40 mM Tris-acetate, 1 mM EDTA) as gel running buffer and a power setting of 8 V/cm. To visualize DNA, add ethidium bromide (0.5 µg/mL) to the gel and visualize the PCR products using a bio-imaging station (Table of Materials).
   7. Excise the amplicons from the gel using a scalpel, purify following the manufacturer's protocol (Table of Materials) and quantify them.
   8. Join AB and CD amplicons by their 21 bp overlapping sequences in the 3' end of PCR products (Figure 3). Mix 100 ng of each amplicon (AB and CD) in a PCR tube with PCR reagents (pre-AD PCR), but without primers, and extend using the thermocycler program (Supplementary Material). Then, add 100 µM of A and D primers to the reaction (AD PCR) and amplify as a single fragment (Supplementary Material).
   9. Analyze the PCR product (AD amplicon) by electrophoresis in a 1% agarose gel using the conditions described in step 2.1.6, excise the amplicon from the gel, purify following the manufacturer's protocol and quantify the amplicon (Table of Materials).
2. Construction of pDM4 recombinant plasmid with the in-frame deletion.
   1. Grow an O/N culture of Escherichia coli cc18λ pir containing pDM4 in Luria-Bertani (LB) Miller broth (10 mL) with chloramphenicol (25 µg/mL) at 30 °C.
   2. Spin down the culture at 5,000 x g at 4 °C and suspend the pellet in 600 µL of sterile distilled water. Perform extraction and purification of plasmid pDM4 using a commercially available plasmid purification kit, following the provider's instructions (Table of Materials).
   3. Digest 1 µg of pDM4 and 400 ng of AD amplicon for 2 h with an endonuclease able to digest both ends of the AD amplicon and the cloning site of pDM4 (Figure 3). Follow the enzyme manufacturer's protocol for reaction conditions (Table of Materials).
   4. Clean up the digested plasmid and amplicon using a DNA purification kit and quantify them following the manufacturer's instructions (Table of Materials).
   5. To prevent religation of the linearized pDM4, remove the phosphate group from both 5' ends using the alkaline phosphatase enzyme following the manufacturer's instructions (Table of Materials). Then, clean up the treated plasmid and quantify it using a spectrophotometer as described in step 2.1.4 (Table of Materials).
   6. Combine 150 ng of the digested and phosphatase alkaline treated pDM4 with 95-100 ng of digested AD amplicon at a molar vector:insert ratio of 1:4. Prepare the ligation reaction in a volume of 15 µL, following the manufacturer's instructions (Table of Materials).
   7. Incubate O/N at 20 °C or over the weekend at 4 °C. After incubation, inactivate the T4 ligase at 70 °C for 20 min.
   8. Use ligation to introduce the plasmid into Escherichia coli MC1061λpir strain by electroporation. Use electrocompetent bacteria and 2 mm-gap electroporation cuvettes.
3. Preparation of electrocompetent E. coli and electroporation of pDM4 recombinant plasmid
   1. Inoculate a single colony of E. coli MC1061λpir strain into Luria-Bertani (LB) Miller broth and grow O/N at 30 °C with 200 rpm shaking.
   2. Dilute 2 mL of the bacterial culture in 18 mL of LB broth and incubate at 30 °C with shaking (200 rpm) until an optical density (OD₆₀₀) between 0.4-0.6 is attained.
   3. Pellet the bacterial culture by centrifugation at 5,000 x g and 4 °C for 15 min. Discard the supernatant and suspend the pellet in 40 mL of chilled distilled H₂O.
   4. Repeat this cleaning step two more times to remove all culture salts. Finally, suspend the pellet in 4 mL of chilled distilled H₂O and transfer 1 mL of the suspension to each of four conical 1.5 mL microfuge tubes.
   5. Pellet the bacterial culture by centrifugation at 14,000 x g and 4 °C for 5 min. Remove the supernatant without disturbing the pellet and suspend each pellet in 100 µL of chilled distilled H₂O.
   6. Add 3-3.5 µL of the ligation mixture to each tube and incubate on ice for 5 min. Then, transfer the contents of each tube to a chilled 2 mm-gap electroporation cuvette and apply 2 kV, 129 Ω, and time constant around 5 ms.
      NOTE: Pre-cool the electroporation cuvettes on ice. Maintain the bacteria on ice during the entire procedure.
   7. After electroporation, add 250 µL of SOC medium to each of the four cuvettes to recover their contents, transfer them to a culture tube (about 1 mL), and incubate for 1 h at 30 °C with shaking (200 rpm).
   8. Plate the transformed cells on Luria-Bertani (LB) agar plates supplemented with chloramphenicol (25 µg/mL) to ensure all colonies growing in the plate have the plasmid backbone.
   9. Pick some colonies from the LB agar plates with chloramphenicol and incubate O/N at 30 °C. When colonies grow, check insertion of the deletion construct into pDM4 by PCR using primers that flank the pDM4 cloning side: pDM4for and pDM4rev (Table 1), and lysed colonies as the template (Supplementary Material).
   10. Pick one colony with a sterile toothpick and dip it into a 1.5 mL tube containing 15 µL of 1% Triton X-100, 20 mM Tris-HCl pH 8.0, 2 mM EDTA pH 8.0. Incubate the tubes at 100 °C for 5 min, and then 1 min on ice.
   11. Spin the tubes in a microfuge at 12,000 x g for 10 min to pellet bacteria and debris. Use 1 µL of the supernatant as the template in the PCR reaction (Table of Materials). The annealing temperature of the primer pair is 50 °C, and the PCR reaction requires 10% DMSO (Supplementary Material).
   12. Inoculate the colonies that amplified the product of interest in 10 mL of LB broth with chloramphenicol (25 µg/mL) and grow O/N at 30 °C. Extract the plasmid from cultures as described in steps 2.2.1-2.2.2. Sequence using the pDM4 primers following the manufacturer's instructions (Table of Materials).
4. Transfer of in-frame deletion to the Aeromonas strain
   NOTE: The pDM4 recombinant plasmid has to be introduced into the selected Aeromonas strain by triparental mating (Figure 4). Aeromonas strain has to be rifampicin-resistant to be selected after the triparental mating. Therefore, grow the selected strains O/N on TSB at 30 °C, centrifuge 2 mL, 4 mL, and 6 mL of cultures at 5,000 x g for 15 min, suspend each pellet in 100 µL of TSB, and plate in TSA with rifampicin (100 µg/mL).
   1. Prepare O/N cultures of E. coli MC1061λpir with the pDM4 recombinant plasmid on LB agar with 25 µg/mL chloramphenicol (donor strain), the Aeromonas strain rifampicin-resistant on TSA with 100 µg/mL rifampicin (recipient strain), and the E. coli HB101 with the pRK2073 plasmid on LB agar with 80 µg/mL spectinomycin (helper strain) at 30 °C.
   2. When the colonies have grown, suspend the same number of colonies (10-15 colonies) of the donor, recipient, and helper strains gently with a sterile toothpick in three LB tubes with 150 µL of LB.
   3. Then, on an LB agar plate, without antibiotics, mix the three bacterial suspensions in two drops at a recipient: helper: donor ratio of 5:1:1 (50 µL of recipient, 10 µL of the donor, and 10 µL of helper). Incubate the plate face up O/N at 30 °C. Perform negative control of conjugation using the donor strain without recombinant plasmid.
      NOTE: The helper strain carries the conjugative plasmid pRK2073 and assists the transfer of the pDM4 into the Aeromonas. Do not use vortex to suspend the donor, recipient, and helper strains to avoid breaking the pili.
   4. Harvest bacteria from the LB agar plate by adding 1 mL of LB broth and spreading it with a sterile glass spreader to obtain a bacterial suspension. Use a pipette to transfer the bacterial suspension to a conical 1.5 mL microfuge tube and vortex vigorously.
   5. To select the recipient colonies containing the pDM4 recombinant plasmid, plate 100 µL of the harvested bacterial suspension on LB agar plates with rifampicin (100 µg/mL) and chloramphenicol (25 µg/mL).
   6. Spin down 200 µL and 600 µL of the samples in a microfuge at 5,000 x g for 15 min, suspend the pellet in 100 µL of LB broth and plate on LB agar with rifampicin (100 µg/mL) and chloramphenicol (25 µg/mL). Incubate all plates for 24-48 h at 30 °C.
   7. Pick up the grown colonies, transfer to LB plates with rifampicin (100 µg/mL) and chloramphenicol (25 µg/mL), and incubate them O/N at 30 °C. Then, confirm that the colonies are Aeromonas by the oxidase test²⁹ and that pDM4 recombinant plasmid was inserted (first recombination) into the specific chromosomal region by PCR using the E and F primers (Supplementary Material), which bind outside the region amplified with the A and D primers (Table of Materials). As described in step 2.3.11, use 1 µL of lysed colonies as the template.
   8. To complete the allelic exchange for the in-frame deletion, coerce the colonies with the integrated suicide plasmid to a second recombination. Grow the recombinant colonies in 2 mL of LB with 10% sucrose and without antibiotics, O/N at 30 °C.
   9. Plate 100 µL of the bacterial cultures from step 2.4.8 on LB agar plate with sucrose (10%). Also, plate 100 µL of different culture dilutions (10^-2-10^-4) and incubate O/N at 30 °C.
   10. To confirm the loss of pDM4, pick up the colonies, transfer to LB plates with and without chloramphenicol (25 µg/mL), incubate them O/N at 30 °C, and then select the chloramphenicol sensitive colonies.
   11. Analyze the sensitive colonies by PCR using the E-F primers pair and 1 µL of lysed colonies as the template (Table of Materials and Supplementary Material). Select the colonies whose PCR product correlated with the size of the deleted construct.

3. Motility assays

NOTE: In some bacterial species with glycosylated flagella, modifications in the levels of glycosylation or glycan composition affect the assembly of flagellins, which is usually reflected as a motility reduction or absence of motility. Therefore, two motility assays were performed with the null mutants.

1. Motility assay in liquid media
   1. Culture Aeromonas strains O/N in 1 mL of TSB at 25-30 °C. To adhere a microscope cover slide to an excavated slide, pick up a small amount of silicone with the tip of a toothpick and put a small drop on the four corners of the cover slide. Then, deposit 1 µL of the Aeromonas culture in the middle of the cover slide and mix in a drop of fresh TSB media (2 µL).
   2. Place an excavated slide on the cover slide. Match the excavation with the deposited drop, press gently, and turn the slide upside down.
   3. Analyze swimming motility by light microscopy using an optic microscope (Table of Materials) with a 100x objective using immersion oil.
      ​NOTE: The wild-type strain of Aeromonas must be used as the positive control. As a negative control, use a non-flagellated bacterium such as Klebsiella.
2. Motility assay in semi-solid media
   1. Culture Aeromonas strains O/N in TSB (1 mL) at 25-30 °C. Then, transfer 3 µL of the culture onto the center of a soft agar plate (1% tryptone, 0.5% NaCl, 0.25% bacto agar) and incubate the plate face up O/N at 25-30 °C.
   2. Using a ruler, measure the bacterial migration through the agar from the plate's center toward the periphery.

4. Flagella purification

1. Isolation of flagella anchored to the bacterial surface
   1. Culture Aeromonas strains O/N in TSB (10 mL) at 25-30 °C. Then, expand the culture into a flask with TSB (900 mL) and let it grow O/N at 25-30 °C with shaking (200 rpm).
   2. Centrifuge at 5,000 x g for 20 min at 4 °C. Suspend the pellet in 20 mL of 100 mM Tris-HCl buffer (pH 7.8).
   3. To remove the anchored flagella, shear the suspension in a vortex with a glass bar (2-3 mm diameter) for 3-4 min, and then pass repetitively (minimum six times) through a 21-G syringe.
   4. Pellet bacteria by two consecutive centrifugations at 4 °C: first, at 8,000 x g for 30 min. Remove the supernatant and centrifuge at 18,000 x g for 20 min. Collect the supernatant, which contains free flagella.
   5. Ultracentrifuge the supernatant at 100,000 x g for 1 h at 4 °C and suspend the pellet in 150 µL of 100 mM Tris-HCl (pH 7.8) plus 2 mM EDTA buffer. The pellet contains flagella filaments.
   6. Analyze 5-10 µL of the resuspended pellet from step 4.1.5 by electrophoresis in a 12% SDS-Polyacrylamide gel and visualize the proteins using Coomassie blue staining.
      NOTE: Follow the manufacturer's instructions for protein electrophoresis and gel staining. As a positive control of glycosylated flagellin, use the purified flagella of the wild-type strain. Purify the enriched fraction of flagella in a cesium chloride (ClCs) gradient.
2. Cesium chloride gradient to purify flagella.
   1. Mix 12.1 g of CsCl with 27 mL of distilled H₂O.
   2. Transfer the enriched fraction of flagella (150 µL) to a thin-walled ultra-clear tube (14 mm x 89 mm) (Table of Materials) and fill it with 12 mL of CsCl solution.
   3. Ultracentrifuge the tube at 60,000 x g for 48 h at 4 °C in a swinging bucket rotor (Table of Materials).
   4. Collect the flagella band into the CsCl gradient with a syringe and dialyze against 100 mM Tris-HCl (pH 7.8) plus 2 mM EDTA. Then, analyze the dialyzed flagella by electrophoresis in a 12% SDS-Polyacrylamide gel and Coomassie blue staining (step 4.1.6) or by mass spectrometry.

Results

This methodology provides an effective system to generate null mutants in genes or chromosomal regions of Aeromonas that can affect flagella glycosylation and the role of flagella filament (Figure 1).

The protocol starts with the bioinformatic identification of putative FGIs and the genes encoding GTs presents in this region. In Aeromonas, the chromosomal location of FGIs is based on the detection of three types of genes: genes involved in the bi...

Discussion

The critical early step of this method is the identification of regions involved in the glycosylation of flagella and putative GTs because these enzymes show high homology and are involved in many processes. Bioinformatic analysis of Aeromonas genomes in public databases shows that this region is adjacent to the polar flagella region 2, which contains the flagellin genes in many strains and contains genes involved in the biosynthesis of pseudaminic acid²⁷. This has made it possible to dev...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
ABI PRISM Big Dye Terminator v. 3.1 Cycle Sequencing Ready Reaction Kit	Applied Biosystems	4337455	Used for sequencing
AccuPrime Taq DNA Polymerase, high fidelity	Invitrogen	12346-086	Used for amplification of AB, CD and AD fragments
Agarose	Conda-Pronadise	8008	Used for DNA electrophoresis
Alkaline phosphatase, calf intestinal (CIAP)	Promega	M1821	Used to remove phosphate at the 5’ end
Bacto agar	Becton Dickinson	214010	Use for motility analysis
BamHI	Promega	R6021	Used for endonuclease restriction
BglII	Promega	R6081	Used for endonuclease restriction
BioDoc-It Imagin System	UVP		Bio-imaging station used for DNA visualization
Biotaq polymerase	Bioline	BIO-21040	Used for colony screening
Cesium chloride	Applichem	A1126,0100	Used for flagella purification
Chloramphenicol	Applichem	A1806,0025	Used for triparental mating
Cytiva illustra GFX PCR DNA and Gel Band Purification Kit	Cytivia	28-9034-71	Used for purification of PCR amplicons and DNA fragments.
EDTA	Applichem	131026.1211	Used for DNA electrophoresis
Electroporation cuvettes 2 mm gap	VWR	732-1133	Used for transformation
Ethidium bromide	Applichem	A1152,0025	Use for DNA visualization
HyperLadder 1 Kb marker	Bioline	BIO-33053	DNA marker
Invitrogen Easy-DNA gDNA Purification Kit	Invitrogen	10750204	Used for bacterial chromosomal DNA purification
Luria-Bertani (LB) Miller agar	Condalab	996	Used for Escherichia coli culture
Luria-Bertani (LB) Miller broth	Condalab	1551	Used for Escherichia coli culture
Nanodrop ND-1000	NanoDrop Techonologies Inc		Spectrophotometer used for DNA quantification
Rifampicin	Applichem	A2220,0005	Used for triparental mating
SOC Medium	Invitrogen	15544034	Used for electroporation recovery
Spectinomycin	Applichem	A3834,0005	Used for triparental mating
SW 41 Ti Swinging-Bucket Rotor	Beckman	331362	Used for flagella purification
T4 DNA ligase	Invitrogen	15224017	Used for ligation reaction
Trypticasein soy agar	Condalab	1068	Used for Aeromonas grown
Trypticasein soy broth	Condalab	1224	Used for Aeromonas grown
Tryptone	Condalab	1612	Use for motility analysis
Tris	Applichem	A2264,0500	Used for DNA electrophoresis and flagella purification
Triton X-100	Applichem	A4975,0100	Used for bacterial lysis
Ultra Clear tubes (14 mm x 89 mm)	Beckman	344059	Used for flagella purification
Veriti 96 well Thermal Cycler	Applied Biosystems		Used for PCR reactions
Zyppy Plasmid Miniprep II Kit	Zymmo research	D4020	Used for isolation of plasmid DNA